115 related articles for article (PubMed ID: 1656927)
1. A clinicopathological study of adenocarcinoma in situ of the cervix. The influence of cervical HPV infection and other factors, and the role of conservative surgery.
Nicklin JL; Wright RG; Bell JR; Samaratunga H; Cox NC; Ward BG
Aust N Z J Obstet Gynaecol; 1991 May; 31(2):179-83. PubMed ID: 1656927
[TBL] [Abstract][Full Text] [Related]
2. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
3. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases.
Andersen ES; Arffmann E
Gynecol Oncol; 1989 Oct; 35(1):1-7. PubMed ID: 2792895
[TBL] [Abstract][Full Text] [Related]
6. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
Tay EH; Yew WS; Ho TH
Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
[TBL] [Abstract][Full Text] [Related]
7. [Cancer of the cervix, papillomavirus, contraception and tobacco].
Thiry L; Vokaer R; Detremmerie O; De Schepper N; Herzog A; Bollen A
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):477-86. PubMed ID: 8228010
[TBL] [Abstract][Full Text] [Related]
8. [Papillomavirus infection and cervical intraepithelial neoplasia (CIN). Study of CINIII in 2 series of conization and hysterectomies (1957-1968 and 1981-1983)].
de Brux J; Ionesco M; Barrasso R
Bull Cancer; 1985; 72(4):290-7. PubMed ID: 2998517
[TBL] [Abstract][Full Text] [Related]
9. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
12. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix.
Shipman SD; Bristow RE
Curr Opin Oncol; 2001 Sep; 13(5):394-8. PubMed ID: 11555719
[TBL] [Abstract][Full Text] [Related]
14. The relationship of risk factors for cervical cancer and HPV in college women.
McQuiston CM
Nurse Pract; 1989 Apr; 14(4):18, 23, 26. PubMed ID: 2540467
[TBL] [Abstract][Full Text] [Related]
15. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
[TBL] [Abstract][Full Text] [Related]
16. The topography and invasive potential of cervical adenocarcinoma in situ, with and without associated squamous dysplasia.
Colgan TJ; Lickrish GM
Gynecol Oncol; 1990 Feb; 36(2):246-9. PubMed ID: 2298414
[TBL] [Abstract][Full Text] [Related]
17. Residual disease and presence of human papillomavirus after conization.
Kanamori Y; Kigawa J; Minagawa Y; Irie T; Oishi T; Itamochi H; Cheng X; Terakawa N
Oncology; 1998; 55(6):517-20. PubMed ID: 9778616
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
Schiffman MH; Bauer HM; Hoover RN; Glass AG; Cadell DM; Rush BB; Scott DR; Sherman ME; Kurman RJ; Wacholder S
J Natl Cancer Inst; 1993 Jun; 85(12):958-64. PubMed ID: 8388478
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of risk of cervical cancer after cytological evidence of human papilloma virus infection.
Mitchell H; Drake M; Medley G
Lancet; 1986 Mar; 1(8481):573-5. PubMed ID: 2869301
[TBL] [Abstract][Full Text] [Related]
20. The suitable treatment for adenocarcinoma in situ of uterine cervix: a report of four cases.
Liu YC; Chen RJ; Chang DY; Huang SC; Chow SN
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Oct; 58(4):294-8. PubMed ID: 8994337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
